ECO Animal Health Group’s (EAH) “Buy” Rating Reiterated at Shore Capital

Shore Capital reiterated their buy rating on shares of ECO Animal Health Group (LON:EAH) in a research report sent to investors on Thursday morning, MarketBeat Ratings reports.

ECO Animal Health Group Stock Performance

LON EAH opened at GBX 63.66 ($0.85) on Thursday. The stock has a fifty day simple moving average of GBX 56.19 and a 200-day simple moving average of GBX 63.85. ECO Animal Health Group has a twelve month low of GBX 50 ($0.67) and a twelve month high of GBX 135 ($1.80). The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.81. The stock has a market cap of £43.14 million, a PE ratio of 41.15 and a beta of -0.05.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.